| Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
|---|
| 02/25/2009 | CN100463909C Synthesis method of thienotetrahydropyridine acetonitrile |
| 02/24/2009 | US7495109 Nociceptin analogs |
| 02/24/2009 | US7495105 dissolving in solvent, adding resolution agent and water, refluxing, cooling, stirring, then filtering; anesthetics; cardiovascular disorders |
| 02/24/2009 | US7495013 Chemokine receptor modulators or Histamine H1 antagonists; autoimmune, inflammatory, proliferative or hyperproliferative diseases, or immune diseases; Methyl 4-[[4-(2,4dichloro-3-methylphenoxy)-1-piperidinyl]methyl]-alpha-(phenylmethyl)-1-piperidineacetate for example |
| 02/24/2009 | US7495012 Arylsulfonamides and uses related thereto |
| 02/24/2009 | US7495001 Benzannelated derivatives, their manufacture and use as pharmaceutical agents |
| 02/24/2009 | US7494987 compounds with potent antitussive actions, high safety and less adverse actions; methyl 4-({1-[2-(4-cyanophenyl)ethyl]-3-hydroxyazetidin-3-ylmethyl}methylamino)benzoate |
| 02/24/2009 | US7494983 di-tert-butyl 4-{[1-(3,3-dimethyl-2-oxobutyl)-6-methoxy-1-H-indazole-3-yl]carbonyl}benzylphosphate; potassium channel blocker; eye neuroprotectant; hypotensive agent; glaucoma, elevated intraoccular pressure in the eye |
| 02/24/2009 | CA2468370C Chronic, bolus administration of d-threo methylphenidate |
| 02/24/2009 | CA2426221C New neurokinin antagonists, processes for preparing them and pharmaceutical compositions containing these compounds |
| 02/19/2009 | WO2009021943A2 Novel preparation process |
| 02/19/2009 | WO2009021942A1 Novel preparation process |
| 02/19/2009 | WO2008148057A3 Cationic lipids compositions and methods for enhancing immune responses to vaccines |
| 02/19/2009 | US20090048299 Biphenyl compounds useful as muscarinic receptor antagonists |
| 02/19/2009 | US20090048291 Novel Piperidine-4-Acetic Acid Derivatives and Their Use |
| 02/19/2009 | US20090048257 Compounds that modulate ppar activity, their preparation and use |
| 02/19/2009 | US20090048236 New phenylalanine derivatives |
| 02/19/2009 | US20090048227 Substituted-1-Phthalazinamines As Vr- 1 Antagonists |
| 02/19/2009 | US20090048224 Compounds and methods of use |
| 02/19/2009 | US20090048220 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors |
| 02/19/2009 | US20090047224 Cosmetic Process for Preventing or Treating the Signs of Skin Ageing or the Orange-Peel Appearance |
| 02/19/2009 | DE102007038250A1 Neues Herstellverfahren New manufacturing process |
| 02/19/2009 | CA2696257A1 Novel preparation process |
| 02/19/2009 | CA2696205A1 Novel preparation process |
| 02/18/2009 | EP2024359A1 Compounds that are agonists of muscarinic receptors and that may be effective in treating pain, alzheimer's decease and/or schizophrenia |
| 02/18/2009 | EP2024354A1 1- [ (4- [benzoyl (methyl) amino]-3- (phenyl) butyl]azetidine derivatives for the treatment of gastrointestinal disorders 1 |
| 02/18/2009 | EP2023927A2 Deoxynojirimycin and d-arabinitol analogs and methods of using |
| 02/18/2009 | EP1497265B1 Compounds having affinity at 5ht2c receptor and use thereof in therapy |
| 02/18/2009 | EP1399431B1 Novel nitriles useful as reversible inhibitors of cysteine proteases |
| 02/18/2009 | CN101370776A 5-(arylsulfonyl)-pyrazolopiperidines |
| 02/18/2009 | CN101367759A Synthesis of high-purity amlodipine besylate |
| 02/18/2009 | CN101367758A Light stabilizer 298 and manufacturing process thereof |
| 02/17/2009 | US7491827 Aryl sulfonamides useful as inhibitors of chemokine receptor activity |
| 02/17/2009 | US7491826 Substituted urea derivatives activate the cardiac sarcomere by potentiating cardiac myosin; systolic heart failure including congestive heart failure; 1-[3-(1-Acetyl-piperidin-3-yloxy)-5-fluoro-phenyl]-3-(6-methoxy-pyridin-3-yl)-urea |
| 02/17/2009 | US7491737 Heterarylpiperidine modulators of chemokine receptor activity |
| 02/17/2009 | US7491736 Use as bronchodilators for treating chronic obstructive pulmonary disease or asthma; long duration of action; reduced side effects, such as dry-mouth and constipation; e.g. biphenyl-2-ylcarbamic acid 1-(2-([4-(4-carbamoylpiperidin-1-ylmethyl)benzoyl]methylamino)ethyl)piperidin-4-yl ester |
| 02/17/2009 | US7491727 Arylpiperazinyl compounds |
| 02/17/2009 | US7491724 Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases |
| 02/17/2009 | US7491723 Alkanol and cycloalkanol-amine derivatives and methods of their use |
| 02/17/2009 | CA2416062C Resolution of the enantiomers of amlodipine |
| 02/17/2009 | CA2316474C Stabilizer mixtures |
| 02/12/2009 | WO2009020140A1 Adamantylurea derivative |
| 02/12/2009 | WO2009019174A1 Benzoyl-piperidine derivatives as dual modulators of the 5-ht2a and d3 receptors |
| 02/12/2009 | WO2009018824A1 Use of a composition comprising at least one beta-blocker for the treatment of sleep disorders |
| 02/12/2009 | WO2008152260A3 Novel rar receptor agonist ligands and use thereof in human medicine and cosmetics |
| 02/12/2009 | US20090043094 Process for trans-4-amino-1-cyclohexanecarboxylic acid derivatives |
| 02/12/2009 | US20090042943 Benzoyl-piperidine derivatives as dual modulators of the 5-ht2a and d3 receptors |
| 02/12/2009 | US20090042942 Muscarinic Receptor Antagonists |
| 02/12/2009 | US20090042938 Chemical Compounds |
| 02/12/2009 | US20090042920 Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 02/12/2009 | US20090042919 Method for modulating gpr119 g protein-coupled receptor and selected compounds |
| 02/12/2009 | US20090042907 Bicyclic aromatic sulfinyl derivatives |
| 02/12/2009 | US20090042899 Piperazinyl-or piperidinylamine-sulfamic acid amides as inhibitors of steroid sulfatase |
| 02/12/2009 | US20090042883 Antitumor agent |
| 02/12/2009 | US20090042855 BENZAMIDE mGluR5 POSITIVE ALLOSTERIC MODULATORS AND METHODS OF MAKING AND USING SAME |
| 02/12/2009 | US20090042851 Sulfonamide derivatives, preparation thereof and use thereof as antagonists of orexin 2 receptors |
| 02/12/2009 | US20090042268 Iminosugar compounds with antiflavirus activity |
| 02/12/2009 | CA2694057A1 Benzoyl-piperidine derivatives as dual modulators of the 5-ht2a and d3 receptors |
| 02/11/2009 | EP2022782A1 Process for production of optically active piperidine compound |
| 02/11/2009 | CN101365680A 3,5-substituted piperidine compounds as renin inhibitors |
| 02/11/2009 | CN101365677A Compounds for the treatment of inflammatory disorders and microbial diseases |
| 02/11/2009 | CN100460392C Catalyst for selective oxidation of protection monosaccharide primary hydroxy group and method thereof |
| 02/11/2009 | CN100460391C Chemical compounds. |
| 02/10/2009 | US7488828 by reaction of 4-alkoxy-1,1,1-trifluorobut-3-en-2-one or 4,4-dialkoxy-1,1,1-trifluorobutan-2-one with a trialkyl phosphonoacetate followed by cyclization |
| 02/10/2009 | US7488824 Process for the production of substituted nicotinic acid esters |
| 02/10/2009 | US7488741 4-Aminopiperidine derivatives, processes for their preparation and their use as medicaments |
| 02/10/2009 | US7488738 Such as 4-({4-[[(4-Amino-2,3,5,6-tetramethylanilino)acetyl]-(methyl)amino]-1-piperidino}methyl)benzamide which has neuroprotective effects by inducing calcium binding proteins |
| 02/10/2009 | US7488737 Each compound having an azabicyclic ring attached via a ring N or amino group; neuroprotectants; neurodegenerative diseases, analgesics, psychological disorders; e.g. 5-Methoxy-N-(8-methyl-8-azabicyclo[3.2.1]oct-3-yl)-1H-indazole-3-carboxamide; ligands for nicotinic acetylcholine receptors |
| 02/10/2009 | US7488731 Arylpiperazinyl compounds |
| 02/10/2009 | CA2208671C Substituted imides as tnf inhibitors |
| 02/05/2009 | WO2009016390A1 Anti-inflammatory composition |
| 02/05/2009 | WO2009016286A2 6-cycloamino-3-(pyridin-4-yl)imidazo[1,2-b]pyridazine derivatives, preparation thereof and therapeutic use thereof |
| 02/05/2009 | WO2009015897A1 Novel heterocyclic compounds as mglu5 antagonists |
| 02/05/2009 | WO2009015867A1 Substituted aryl or heteroarylpiperdine derivatives as melanocortin-4 receptor modulators |
| 02/05/2009 | WO2009015485A1 Cyclic inhibitors of carnitine palmitoyltransferase and treating cancer |
| 02/05/2009 | US20090036444 5-5-Membered fused heterocyclic compound and use thereof as HCV polymerase inhibitor |
| 02/05/2009 | US20090036429 Hydroxypiperidine Derivatives and Uses Thereof |
| 02/05/2009 | US20090036423 Immunosuppresant compounds and compositions |
| 02/05/2009 | US20090036420 Benzamide derivatives and their use for treating cns disorders |
| 02/05/2009 | US20090036412 Methods and Compositions for Inhibition of Angiogenesis |
| 02/05/2009 | US20090033210 Compound and organic light emitting device |
| 02/05/2009 | CA2695496A1 N-piperidin-4-ylmethyl-amide derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 02/05/2009 | CA2695257A1 Anti-inflammatory composition |
| 02/05/2009 | CA2694724A1 Cyclic inhibitors of carnitine palmitoyltransferase and treating cancer |
| 02/05/2009 | CA2694359A1 Novel heterocyclic compounds as mglu5 antagonists |
| 02/05/2009 | CA2691866A1 6-cycloamino-3-(pyridin-4-yl)imidazo[1,2-b]pyridazine derivatives, preparation thereof and therapeutic use thereof |
| 02/05/2009 | CA2677049A1 Cyclic inhibitors of carnitine palmitoyltransferase and treating cancer |
| 02/04/2009 | EP2020409A1 New piperidinyl derivatives as modulators of chemokine receptor activity |
| 02/04/2009 | EP2020405A1 Substituted aryl or heteroarylpiperidine derivatives as melanocortin-4 receptor modulators |
| 02/04/2009 | CN101360712A New pleuromutilin derivative and its use |
| 02/04/2009 | CN101360711A L-phenylalanine derivatives and its application as integrin antagonists |
| 02/04/2009 | CN101360710A Salt and preparation thereof |
| 02/04/2009 | CN101357901A Chiral 1,4-dihydro-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic carboxylate, preparation method and application thereof |
| 02/04/2009 | CN101357900A Purification method of irinotecan hydrochloride intermediate 4-piperidinopiperidine |
| 02/04/2009 | CN100457753C N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl] carboxamide inhibitors of cyclin dependent kinases |
| 02/04/2009 | CN100457738C Aryloxyphenyl and arylsulfanylphenyl piperazine derivatives |
| 02/04/2009 | CN100457726C Substituted sulfonamide compounds, process for their use as medicament for the treatment of CNS disorders, obestity and type II diabetes |
| 02/04/2009 | CN100457715C Process for the hydrogenation of aromatic compounds |
| 02/03/2009 | US7485728 Colorant compounds |
| 02/03/2009 | US7485706 Has a domain that preferentially binds to aggregations comprising at least two monomeric proteins linked to a second domain that recruits the aggregation modifying protein; neurotoxicity; neurodegenerative diseases |